144177-44-6Relevant articles and documents
SELECTIVE FKBP51 LIGANDS FOR TREATMENT OF PSYCHIATRIC DISORDERS
-
Page/Page column 132, (2015/04/15)
The present invention relates to compounds of the general formula (I) having a selective FKBP51 ligand scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with
A ring-closing metathesis-mediated route to novel enantiopure conformationally restricted cyclic amino acids
Tjen, Kim C. M. F.,Kinderman, Sape S.,Schoemaker, Hans E.,Hiemstra, Henk,Rutjes, Floris P. J. T.
, p. 699 - 700 (2007/10/03)
A combination of palladium-catalysed N,O-acetal formation, ruthenium- catalysed ring-closing metathesis and N-sulfonyliminium ion-mediated C-C bond formation constitutes an efficient and versatile route to a set of enantiomerically pure 2,6-disubstituted unsaturated pipecolic acid derivatives.